Cardiometabolic diseases are conditions affecting the heart or blood vessels; they represent the leading cause of death worldwide.
Over the last two decades the interest in omega-3 polyunsaturated fatty acids (PUFAs) has grown, thanks to their antidyslipidemic, anti-inflammatory, antiarrhythmic and antithrombotic properties. When not sufficiently provided with the diet, omega-3 obtained by esterification of triglycerides extracted from fish oil can be assumed alternatively as drugs. IBSA products contain omega -3 fatty acids (EPA/DHA) which have been certified as sustainably sourced by the NGO Friends of the Sea and have obtained the IFOS Five Star Certification for their purity, freshness and concentration. IBSA’s omega-3 are enclosed in a soft gelatine capsule that preserves their integrity and stability over time.
Recently in the cardiometabolic area IBSA has also developed two nutraceutical formulations containing monacolin k and other components that help maintaining the normal cholesterol levels in the blood.